Concord Medical Services Holdings Limited (CCM)
NYSE: CCM · Real-Time Price · USD
7.78
-0.42 (-5.12%)
May 15, 2025, 1:22 PM - Market open
CCM Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Revenue | 383.96 | 537.4 | 472.09 | 485.63 | 223.01 | Upgrade
|
Revenue Growth (YoY) | -28.55% | 13.84% | -2.79% | 117.76% | 12.43% | Upgrade
|
Cost of Revenue | 463.12 | 614.01 | 624.49 | 542.53 | 209.93 | Upgrade
|
Gross Profit | -79.16 | -76.61 | -152.41 | -56.9 | 13.08 | Upgrade
|
Selling, General & Admin | 453 | 386.38 | 372.64 | 401.42 | 320.58 | Upgrade
|
Operating Expenses | 453 | 386.38 | 372.64 | 401.42 | 320.58 | Upgrade
|
Operating Income | -532.16 | -462.99 | -525.05 | -458.32 | -307.5 | Upgrade
|
Interest Expense | -193.2 | -165.67 | -120.36 | -73.79 | -81.36 | Upgrade
|
Interest & Investment Income | 13.98 | 10.83 | 10.02 | 5.89 | 8.44 | Upgrade
|
Earnings From Equity Investments | 12.7 | 20.79 | 17.65 | 18.16 | 6.02 | Upgrade
|
Currency Exchange Gain (Loss) | -17.47 | 10.15 | 54.98 | -19.93 | -58.69 | Upgrade
|
Other Non Operating Income (Expenses) | -9.1 | -5.57 | -11.35 | -1.26 | 6.31 | Upgrade
|
EBT Excluding Unusual Items | -725.25 | -592.45 | -574.1 | -529.24 | -426.77 | Upgrade
|
Gain (Loss) on Sale of Investments | 7.17 | 37.5 | - | - | 7.84 | Upgrade
|
Gain (Loss) on Sale of Assets | 48.5 | -0.64 | -61.55 | - | -14.22 | Upgrade
|
Asset Writedown | - | - | - | - | -8.5 | Upgrade
|
Other Unusual Items | - | - | -204.25 | - | - | Upgrade
|
Pretax Income | -669.58 | -555.59 | -839.9 | -529.24 | -441.65 | Upgrade
|
Income Tax Expense | -17.51 | -24.57 | -70.91 | -6.57 | -37.62 | Upgrade
|
Earnings From Continuing Operations | -652.08 | -531.02 | -768.99 | -522.67 | -404.03 | Upgrade
|
Net Income to Company | -652.08 | -531.02 | -768.99 | -522.67 | -404.03 | Upgrade
|
Minority Interest in Earnings | 343.83 | 233.36 | 279.33 | 251.25 | 94.04 | Upgrade
|
Net Income | -308.24 | -297.66 | -489.66 | -271.43 | -309.99 | Upgrade
|
Preferred Dividends & Other Adjustments | - | - | - | 549.19 | 359.92 | Upgrade
|
Net Income to Common | -308.24 | -297.66 | -489.66 | -820.62 | -669.91 | Upgrade
|
Shares Outstanding (Basic) | 4 | 4 | 4 | 4 | 4 | Upgrade
|
Shares Outstanding (Diluted) | 4 | 4 | 4 | 4 | 4 | Upgrade
|
Shares Change (YoY) | - | - | - | - | 0.63% | Upgrade
|
EPS (Basic) | -70.56 | -68.14 | -112.09 | -187.85 | -153.35 | Upgrade
|
EPS (Diluted) | -70.56 | -68.14 | -112.09 | -187.85 | -153.35 | Upgrade
|
Free Cash Flow | -798.42 | -392.17 | -600.47 | -1,120 | -734.47 | Upgrade
|
Free Cash Flow Per Share | -182.77 | -89.77 | -137.46 | -256.36 | -168.13 | Upgrade
|
Gross Margin | -20.62% | -14.26% | -32.28% | -11.72% | 5.87% | Upgrade
|
Operating Margin | -138.60% | -86.15% | -111.22% | -94.38% | -137.89% | Upgrade
|
Profit Margin | -80.28% | -55.39% | -103.72% | -168.98% | -300.39% | Upgrade
|
Free Cash Flow Margin | -207.95% | -72.98% | -127.19% | -230.60% | -329.34% | Upgrade
|
EBITDA | -411.03 | -344.16 | -401.86 | -363.86 | -236.72 | Upgrade
|
EBITDA Margin | -107.05% | -64.04% | -85.13% | -74.92% | -106.14% | Upgrade
|
D&A For EBITDA | 121.13 | 118.83 | 123.19 | 94.46 | 70.79 | Upgrade
|
EBIT | -532.16 | -462.99 | -525.05 | -458.32 | -307.5 | Upgrade
|
EBIT Margin | -138.60% | -86.15% | -111.22% | -94.38% | -137.89% | Upgrade
|
Revenue as Reported | 383.96 | 537.4 | 472.09 | 485.63 | 223.01 | Upgrade
|
Updated Sep 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.